Atara Biotherapeutics
ATRA
ATRA
84 hedge funds and large institutions have $508M invested in Atara Biotherapeutics in 2015 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 18 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
65% less call options, than puts
Call options by funds: $472K | Put options by funds: $1.35M
Holders
84
Holding in Top 10
2
Calls
$472K
Puts
$1.35M
Top Buyers
| 1 | +$12.8M | |
| 2 | +$12.7M | |
| 3 | +$9.16M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$7.68M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$6.97M |
Top Sellers
| 1 | -$26.5M | |
| 2 | -$25.3M | |
| 3 | -$24.1M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$4.54M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$3.14M |